EUVIMEDEUVIMED entdecken
Crossref

Translocator protein alleviates allodynia and improves Schwann cell function against diabetic peripheral neuropathy via activation of the Nrf2‐dependent antioxidant system and promoting autophagy

Nan Gao, Bingjie Ma, Hongbin Jia, Can Hao, Tian Jin, Xiaoming Liu

Diabetic Medicine · 2023

DOI: 10.1111/dme.15090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetic Medicine, 2023. Verfasst von Nan Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pain Management Center, Shanghai Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 210092, China. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In diabetes, autophagy and the nuclear factor erythroid‐derived‐2‐like 2 (Nrf2)‐dependent antioxidant system are impaired. Translocator protein (TSPO) agonist Ro5‐4864 alleviates neuropathic pain, including diabetic peripheral neuropathy (DPN). However, the precise mechanisms remain unclear. Thus, we investigated the effects of Ro5‐4864 on autophagy and the Nrf2‐dependent antioxidant system in the sciatic nerves of DPN rats.

Methods

All rats were randomly assigned to Sham or DPN group. After type 2 diabetes modelling (established by high‐fat diet and streptozotocin injection) followed by behavioural tests, established DPN rats were randomly assigned to the DPN group, the Ro (TSPO agonist Ro5‐4864) group, the Ro + 3‐MA (autophagy inhibitor) group and the Ro + ML385 (Nrf2 inhibitor) group. Behavioural assessments were performed at baseline, on days 3, 7, 14, 21 and 28. Sciatic nerves were collected on day 28 for immunofluorescence, morphological and western blot analyses.

Results

Ro5‐4864 alleviated allodynia and increased myelin sheath thickness and myelin protein expression after DPN. Beclin‐1 ( p < 0.01) and LC3‐II/LC3‐I ratio ( p < 0.01) decreased and p62 ( p < 0.01) accumulated in the DPN rats. Ro5‐4864 administration increased the Beclin‐1 and LC3‐II/LC3‐I ratio and decreased p62 accumulation. Furthermore, nuclear Nrf2 contents ( p < 0.01) and cytoplasmic HO‐1 ( p < 0.01) and NQO1 ( p < 0.01) expressions were significantly inhibited in the DPN rat, which was also improved by Ro5‐4864. All the beneficial effects were abrogated by 3‐MA or ML385.

Conclusion

TSPO exhibited a potent analgesic effect and improved Schwann cell function and regeneration against DPN by activating the Nrf2‐dependent antioxidant system and promoting autophagy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesDiabetes Mellitus, Type 2RatsAnimalsAntioxidantsNF-E2-Related Factor 2Beclin-1HyperalgesiaSchwann CellsAutophagy

Stichwörter der Autor:innen

autophagydiabetic peripheral neuropathynuclear factor erythroid-derived-2-like 2translocator protein

Substanzen

AntioxidantsNF-E2-Related Factor 2Beclin-1

Autor:innen und Institutionen

  • Pain Management Center, Shanghai Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 210092, China.
  • Pain Management Center, Nanjing Jinling Hospital, Nanjing, 210002, China.

Zitieren

APA

Gao, N., Ma, B., Jia, H., Hao, C., Jin, T., & Liu, X. (2023). Translocator protein alleviates allodynia and improves Schwann cell function against diabetic peripheral neuropathy via activation of the Nrf2‐dependent antioxidant system and promoting autophagy. Diabetic Medicine. https://doi.org/10.1111/dme.15090

Vancouver

Gao N, Ma B, Jia H, Hao C, Jin T, Liu X. Translocator protein alleviates allodynia and improves Schwann cell function against diabetic peripheral neuropathy via activation of the Nrf2‐dependent antioxidant system and promoting autophagy. Diabetic Medicine. 2023. doi:10.1111/dme.15090

BibTeX
@article{Gao2023,
  author = {Gao, Nan and Ma, Bingjie and Jia, Hongbin and Hao, Can and Jin, Tian and Liu, Xiaoming},
  title = {Translocator protein alleviates allodynia and improves Schwann cell function against diabetic peripheral neuropathy via activation of the Nrf2‐dependent antioxidant system and promoting autophagy},
  journal = {Diabetic Medicine},
  year = {2023},
  doi = {10.1111/dme.15090}
}
Kostenlos starten →